Searchable abstracts of presentations at key conferences in endocrinology

Endocrine Abstracts

Published by BioScientifica
Previous issue | Volume 41 | ECE2016 | Next issue

18th European Congress of Endocrinology

Eposter Presentations

Diabetes therapy

Previous section
Diabetes complications
Table of contents
Next section
Endocrine Disruptors

ea0041ep538 | Diabetes therapy

Liraglutide as additional treatment to insulin in patient with latent autoimmune diabetes in adults (LADA): a case report

ea0041ep539 | Diabetes therapy

Patients’ understanding of hypoglycaemia in tertiary referral centers

ea0041ep540 | Diabetes therapy

Impact of obesity on management of type 2 diabetes

ea0041ep541 | Diabetes therapy

PPARG2 Pro12Ala, TNFα G(308)A and G(238)A, LIPC C(-514)T, ACE I/D, SLCO1B1 Val174Ala polymorphism as predictors of lipid-lowering response to statin therapy in patients with T2DM

ea0041ep542 | Diabetes therapy

Add on exenatide treatment in obese type 2 diabetic patients under intensive insulin regiments

ea0041ep543 | Diabetes therapy

The impact of insulin sensitisation with metformin on lung function in patients with type 2 diabetes mellitus and chronic obstructive pulmonary disease

ea0041ep544 | Diabetes therapy

Potential glycemic overtreatment in diabetics patients older than 70 years and comorbid conditions: real-life experience

ea0041ep545 | Diabetes therapy

Long-term effects of Stevia rebaduiana on glucose and lipid profile, adipocytokines, markers of inflammation and oxidation status in patients with metabolic syndrome

ea0041ep546 | Diabetes therapy

Evaluation of three continuous glucose monitoring systems during exercise and meal challenges

ea0041ep547 | Diabetes therapy

The effects of vitamin D on advanced glycation end-products in prediabetic and type 2 diabetic patients with vitamin D deficiency

ea0041ep548 | Diabetes therapy

Intensive therapy with insulin pump in type 1 diabetes mellitus

ea0041ep549 | Diabetes therapy

Potential use of embryonic antitumor modulator (EATM) for diabetes prevention and treatment

ea0041ep550 | Diabetes therapy

Effects in weight loss and HbA1c after one year of use of dapaglifozina

ea0041ep551 | Diabetes therapy

An assessment of factors related with understanding education and knowledge of self-care among patients with diabetes mellitus: a cross sectional prospective study in two cities of Turkey

ea0041ep552 | Diabetes therapy

Associated antidiabetic treatment in a rural population with type 2 diabetes mellitus

ea0041ep553 | Diabetes therapy

Abstract unavailable

ea0041ep554 | Diabetes therapy

Economic impact on the use of insulin pumps in diabetes type I – analysis on Portuguese real life results

ea0041ep555 | Diabetes therapy

Effects of GLP-1 analogues in the treatment of a population with DM2

ea0041ep556 | Diabetes therapy

Effects of SGLT2 inhibitors in the treatment of a population with type 2 diabetes mellitus

ea0041ep557 | Diabetes therapy

Randomized clinical trial to compare the effects of glargine multidosis versus CSII therapy on metabolic and oxidative stress parameters in people with type 1 diabetes

ea0041ep558 | Diabetes therapy

Dapagliflozin clinical experience and safety on patients with type 2 diabetes and obesity

ea0041ep559 | Diabetes therapy

Lixisenatide effects on liver function, lipids and blood pressure levels

ea0041ep560 | Diabetes therapy

Predictive factors in the management and the prognosis of Korean women with gestational diabetes mellitus

ea0041ep561 | Diabetes therapy

Non-surgical reversal of type 2 diabetes mellitus

ea0041ep562 | Diabetes therapy

Insulin pump therapy-a different solution for treating diabetes type I

ea0041ep563 | Diabetes therapy

Make sense of insulin

ea0041ep564 | Diabetes therapy

GLP-1-RAs treatment in type 2 diabetes and obesity patients

ea0041ep565 | Diabetes therapy

The effect of diabetes on the duration and cost of treatment in patients with acute ischemic stroke

ea0041ep566 | Diabetes therapy

Quality of life domains are affected in caregivers of people with type 2 diabetes: results from a literature review

ea0041ep567 | Diabetes therapy

Effects of gender on IGF1 changes after initial basal insulin analog therapy in the type 2 diabetics

ea0041ep568 | Diabetes therapy

Half of three regimen for treatment of T2 DM in low income populations

ea0041ep569 | Diabetes therapy

Combined metformin-associated lactic acidosis and euglycaemic ketoacidosis

ea0041ep570 | Diabetes therapy

The effect of liraglutide in patients with type 2 diabetes mellitus: clinical and metabolic characteristics

ea0041ep571 | Diabetes therapy

Analysis and metabolic evaluation in a standard clinical setting of a group of patients 7 years after a clinical trial with sensor-augmented pump (SAP)

ea0041ep572 | Diabetes therapy

Ameliorative effects of Treculia Africana aqueous seed extract on hyperglycemia and testicular histopathological alterations in alloxan-diabetic rats

ea0041ep573 | Diabetes therapy

The influence of α-lipoic acid to endothelial dysfunction and adipokines balance in patients with type 2 diabetes and essential hypertension in the presence of unfavorable genetic polymorphism

ea0041ep574 | Diabetes therapy

Role of community pharmacists in the prevention and management of the metabolic syndrome in Albania

ea0041ep575 | Diabetes therapy

Galangin, a dietary flavonoid improves antioxidant status and reduces hyperglycemia mediated oxidative stress in streptozotocin-induced diabetic rats

ea0041ep576 | Diabetes therapy

Trends and differences between sexes in control of diabetes and cardiovascular risk factors from 2004 to 2014

ea0041ep577 | Diabetes therapy

Antidepressant treatment worsens metabolic control in type 2 diabetes mellitus

ea0041ep578 | Diabetes therapy

The need of change in the treatment options for diabetes in acute ischemic stroke

ea0041ep579 | Diabetes therapy

Effect of short term GLP-1 modifying therapy on intima media thickness

ea0041ep580 | Diabetes therapy

Protocol for the hyperglycemia and diabetes mellitus in hospitalization

ea0041ep581 | Diabetes therapy

Diabetic hyperlipidemia: from guidelines into clinical practice

Published by BioScientifica

Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more